Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Do Non Stimulant Medications Require Time to Accumulate in the System?

Posted
Updated
ByMy Patient Advice
Author: Avery Lombardi, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Yes, non stimulant ADHD medication onset is typically slower compared to stimulant medications, meaning these drugs often require time to accumulate in the system before they fully take effect. Unlike stimulants, which provide quicker symptom relief, non stimulants like Strattera (atomoxetine) and Intuniv (guanfacine) usually take several weeks to reach their full effectiveness.

Private ADHD assessment in the UK

Steady State and Treatment Delay

For non stimulant ADHD medications, it can take time for the medication to build up to a steady state in the body, where it consistently produces therapeutic effects. This is because non stimulants are metabolised more slowly and don’t provide the rapid dopamine boosts seen with stimulants. As a result, treatment delay can occur, with noticeable improvements typically seen after 2–4 weeks of consistent use.

Why the Delay?

The delay in onset is due to how non stimulant medications work. They target norepinephrine and other neurotransmitters in a more gradual way, leading to slower symptom management. For example, Strattera works by inhibiting norepinephrine reuptake, which takes longer to show results, whereas Intuniv works by regulating the brain’s alpha 2 receptors, producing more stable effects over time.

Benefits of Non Stimulants

While the delayed onset might be inconvenient for some, non stimulant medications offer several benefits, including fewer side effects like anxiety and sleep disturbances, which are common with stimulants. They also carry a lower risk of misuse, making them a safer choice for individuals with a history of substance abuse.

In conclusion, non stimulant ADHD medication onset is slower because these medications need time to reach a steady state. While results take longer, they offer a consistent, long term solution for managing ADHD symptoms.

Visit providers like ADHD Certify for personal consultations and expert guidance tailored to your unique situation.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our Complete guide to Medications for ADHD.

Private ADHD assessment in the UK
Avery Lombardi, MSc
Author

Avery Lombardi is a clinical psychologist with a Master’s in Clinical Psychology and a Bachelor’s in Psychology. She has professional experience in psychological assessment, evidence-based therapy, and research, working with both child and adult populations. Avery has provided clinical services in hospital, educational, and community settings, delivering interventions such as CBT, DBT, and tailored treatment plans for conditions including anxiety, depression, and developmental disorders. She has also contributed to research on self-stigma, self-esteem, and medication adherence in psychotic patients, and has created educational content on ADHD, treatment options, and daily coping strategies.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS
Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories